Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page
- Check5 days agoChange DetectedPage revision tag updated from v3.6.4 to v3.6.5, indicating a small backend/content update rather than a visible change to study information or user-facing features.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating a small site version update.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page. The change does not modify study data, eligibility criteria, or results.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page's revision version was updated from v3.6.0 to v3.6.2, indicating a deployment update with potential minor fixes or improvements not related to the study details.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page adds recruitment status indicating no participants are being sought and introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study), while adjusting the Intervention/Treatment header formatting and updating the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check69 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, signaling a minor update to the page. This change does not alter study details, eligibility criteria, or results.SummaryDifference0.1%

Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.